Black Diamond Therapeutics, Inc. (BDTX) has a market capitalization of $152.39M and trades at $2.66. The 52-week range is 1.195-4.94.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of 6.8, Earnings Per Share (EPS) of $0.39, annual revenue of $70M.
The stock has a beta of 3.39, operates in the Healthcare sector.
